A physiologically-based pharmacokinetic (PBPK) model of hydroxychloroquine

被引：0
|
作者：
Collins, Keagan P.
Jackson, Kristen M.
Gustafson, Daniel L.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1503
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1503
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Physiologically-based pharmacokinetic (PBPK) model to describe the disposition of pyronaridine
    Diep, John K.
    Lingerfelt, Mary A.
    Ekins, Sean
    Rao, Gauri G.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S34 - S34
  • [2] PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR PANTOPRAZOLE IN CHILDREN WITH OBESITY
    Kyler, K.
    Shakhnovich, V.
    Selvarangan, R.
    Sasidharan, A.
    Chan, S.
    Artz, N.
    Williams, V.
    Friesen, C.
    Pearce, R.
    Gaedigk, A.
    Leeder, J.
    Galetin, A.
    Johnson, T.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S106 - S107
  • [3] Development of a Physiologically-Based Pharmacokinetic (PBPK) Model of Nebulized Hydroxychloroquine for Pulmonary Delivery to COVID-19 Patients
    Idkaidek, Nasir
    Hawari, Feras
    Dodin, Yasmeen
    Obeidat, Nour
    [J]. DRUG RESEARCH, 2021, 71 (05) : 250 - 256
  • [4] A physiologically-based pharmacokinetic/pharmacodynamic (PBPK/PD) model for the insecticide dimethoate
    Reiss, Richard
    Loccisano, Anne
    Deines, Andrew
    Kim, Myoungwoo
    Nallani, Gopinath
    Chandrasekaran, Appavu
    Whatling, Paul
    [J]. XENOBIOTICA, 2023, 53 (05) : 382 - 395
  • [5] A physiologically-based pharmacokinetic (PBPK) model for alcohol facilitates rapid BrAC clamping
    Ramchandani, VA
    Bolane, J
    Li, TK
    O'Connor, S
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1999, 23 (04) : 617 - 623
  • [6] A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines
    Tegenge, Million A.
    Mitkus, Robert J.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 (05) : 545 - 556
  • [7] A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines
    Million A. Tegenge
    Robert J. Mitkus
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2013, 40 : 545 - 556
  • [8] Development of Physiologically-Based Pharmacokinetic (PBPK) model for biodistribution of radiolabeled peptides in human body
    Gospavic, R.
    Knoll, P.
    Mirzaei, S.
    Popov, V.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S342 - S342
  • [9] A physiologically-based pharmacokinetic (PBPK) and pharmacodynamic (PD) model of docetaxel (Doc) and neutropenia in humans
    Florian, J. A., Jr.
    Egorin, M. J.
    Zamboni, W. C.
    Eiseman, J. L.
    Lagattuta, T. F.
    Belani, C. P.
    Chatta, G. S.
    Scher, H. I.
    Solit, D. B.
    Parker, R. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] VARIABILITY OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL PARAMETERS AND THEIR EFFECTS ON PBPK MODEL PREDICTIONS IN A RISK ASSESSMENT FOR PERCHLOROETHYLENE (PCE)
    GEARHART, JM
    MAHLE, DA
    GREENE, RJ
    SECKEL, CS
    FLEMMING, CD
    FISHER, JW
    CLEWELL, HJ
    [J]. TOXICOLOGY LETTERS, 1993, 68 (1-2) : 131 - 144
12345